Directory

Don Yee

Contact Overview Publications

Contact

Faculty of Medicine & Dentistry - Oncology Dept
Email
dony@ualberta.ca
Phone
(780) 432-8783
Address
Cross Cancer Institute
11560 University Avenue
Edmonton AB
T6G 1Z2

Overview

Area of Study / Keywords

About

Clinical Interests
Genitourinary, Small cell lung cancers

Research

Current Research Interests: the application of state-of-the-art diagnostic and treatment planning and delivery modalities to GU and gynecologic malignancies.  Dose escalation for small cell lung cancer.

Featured Publications

Conventional Versus Hypofractionated Radiation for High-Risk Prostate Cancer Patients (CHIRP): 24-Month Patient-Reported Outcomes of the Randomized Phase 2 CHIRP Trial

Yang F., Ghosh S., Yee D., Patel S., Pervez N., Parliament M., Usmani N., Danielson B., Amanie J., Pearcey R., Field C., Fallone G., Murtha A.

International Journal of Radiation Oncology Biology Physics. 2022 September; 114 (1):99-107 10.1016/j.ijrobp.2022.04.045

Metformin for prevention of anthropometric & metabolic complications of androgen deprivation therapy in prostate cancer patients receiving radical radiotherapy: A phase II randomized controlled trial

Usmani N, Ghosh S, Sanghera KP, Ong AD, Koul R, Dubey D, Ahmed S, Quon H, Yee D, Parliament M, Sivananthan G, Hunter W, Danielson B, Rowe L, McDonald M, Kim JO

International Journal of Radiation Oncology Biology Physics. 2022 July; Online ahead of print 10.1016/j.ijrobp.2022.07.035

Conventional versus hypofractionation radiation for high-risk prostate cancer patients (CHIRP): 24 months patient-reported quality of life outcomes of the randomized phase II CHIRP trial.

Int J Radiat Oncol Biol Phys. 2022 April;

Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial

Jones C.U., Pugh S.L., Sandler H.M., Chetner M.P., Amin M.B., Bruner D.W., Zietman A.L., Den R.B., Leibenhaut M.H., Longo J.M., Bahary J.P., Rosenthal S.A., Souhami L., Michalski J.M., Hartford A.C., Amin P.P., Roach M., Yee D., Efstathiou J.A., Rodgers J.P., Feng F.Y., Shipley W.U.

International Journal of Radiation Oncology Biology Physics. 2022 February; 112 (2):294-303 10.1016/j.ijrobp.2021.08.031

Clinical Learning, Didactic Education, and Research Experiences of Radiation Oncology Resident Physicians in Canada

Wang M.H., Loewen S.K., Giuliani M., Fairchild A., Yee D., Debenham B.J.

Journal of Cancer Education. 2022 February; 37 (1):155-162 10.1007/s13187-020-01799-x

Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial

Kim J.O., McDonald M.O., Ong A., Koul R., Dubey A., Hunter W., Ahmed S., Quon H., Yee D., Parliament M., Sivananthan G., Danielson B., Rowe L., Ghosh S., Usmani N.

Radiation Oncology. 2021 November; 16 (1):212 10.1186/s13014-021-01935-x

Conventional versus hypofractionation radiation for high-risk prostate cancer patients (CHIRP): 24 months patient-reported quality of life outcomes of the randomized phase II CHIRP trial.

Radiotherapy and Oncology. 2021 October;

Motivations, Well-Being, and Career Aspirations of Radiation Oncology Resident Physicians in Canada

Wang M.H., Loewen S.K., Giuliani M., Fairchild A., Yee D., Debenham B.J.

Journal of Cancer Education. 2021 October; 36 (5):933-940 10.1007/s13187-020-01717-1

Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer

Wang M.H., Vos L.J., Yee D., Patel S., Pervez N., Parliament M., Usmani N., Danielson B., Amanie J., Pearcey R., Ghosh S., Field C., Fallone B.G., Murtha A.D.

Practical Radiation Oncology. 2021 September; 11 (5):384-393 10.1016/j.prro.2021.02.011

Deep learning-based auto-contouring algorithm for tumour tracking using a Linac-MR

2021 Annual Scientific Meeting of the Canadian Organization of Medical Physicists (COMP). 2021 January;